Mouse mammary stem cells express prognostic markers for triple-negative breast cancer

INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous group of tumours in which chemotherapy, the current mainstay of systemic treatment, is often initially beneficial but with a high risk of relapse and metastasis. There is currently no means of predicting which TNBC will relapse. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Soady, Kelly J, Kendrick, Howard, Gao, Qiong, Tutt, Andrew, Zvelebil, Marketa, Ordonez, Liliana D, Quist, Jelmar, Tan, David Wei-Min, Isacke, Clare M, Grigoriadis, Anita, Smalley, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381533/
https://www.ncbi.nlm.nih.gov/pubmed/25849541
http://dx.doi.org/10.1186/s13058-015-0539-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381533/
https://www.ncbi.nlm.nih.gov/pubmed/25849541
http://dx.doi.org/10.1186/s13058-015-0539-6

Ejemplares similares